pharmaphorum

SEPTEMBER 12, 2022

Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. In other words, every person’s cancer has its own genetic construct. Tailored oncology.

Genome 105

Genome Genomics Clinical Trials Clinical Trials 105

Scienmag

SEPTEMBER 22, 2020

– A Purdue Foundry-affiliated company with a growing reputation as a search engine for genome sequence data in life sciences has joined a nationally ranked health care startup accelerator. Credit: Karyosoft/Rajesh Perianayagam WEST LAFAYETTE, Ind.

Genomics 98

Genomics Genome Life Science Engineer 98

XTalks

NOVEMBER 10, 2020

Expeditious and accurate diagnoses are necessary for patients to access healthcare services and treatment options for rare genetic diseases. Increasing the efficiency of case analysis and interpretation is essential to providing timely care for patients with genetic diseases.

Genome 98

Genome Genomics Medicine Genetic Disease 98

Medical Xpress

APRIL 11, 2023

With the huge abundance of genomic data generated from life science experiments, processing large datasets remains a challenge in the field of bioinformatics.

Genomics 75

Genomics Genome Bioinformatics Life Science 75

XTalks

MARCH 21, 2025

The company also launched Learn NPC, an awareness campaign aimed at improving early diagnosis and supporting families affected by this rare genetic disorder. This enhancement supports large-scale initiatives like the GUARDIAN study, which aims to screen around 100,000 babies for over 460 genetic conditions.

Genome 59

Genome Genomics FDA Approval Trials 59

pharmaphorum

OCTOBER 2, 2020

Swiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be used to boost its headcount and international presence and prepare to take its shares public. The post $110m financing sets up US, Asia expansion for Sophia Genetics appeared first on.

Genetics 59

Genetics Genome Genomics Life Science 59

The Pharma Data

JANUARY 31, 2021

Illumina , the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. It is dubbed the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Life Science 52

Life Science Genome Genomics Reagent 52

XTalks

FEBRUARY 21, 2025

Current Share Price: PWS is a complex, genetically determined neurodevelopmental disorder that affects multiple organ systems. And hyperphagia is common not only to PWS but also to hypothalamic obesity, binge-eating disorder and certain rare genetic disorders like Bardet-Biedl syndrome.

Genetics 59

Genetics Hormones Gene Expression Gene 59

Drug Discovery Today

AUGUST 5, 2021

(Oslo, August 5, 2021) Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced the first publication from the comprehensive HumGut microbiome database has appeared in the leading scientific journal Microbiome.

Genetic Analysis 40

Genetic Analysis Genome Genomics Genetics 40

pharmaphorum

OCTOBER 7, 2021

However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. He also serves as haematology consultant to the NICU and genetics service and is co-director of the NIH/Johns Hopkins Pediatric Hematology/Oncology Fellowship Program. About IQVIA.

Genome 98

Genome Genomics Medicine Life Science 98

XTalks

MARCH 24, 2021

The research team conducted a genome-wide association study (GWAS) for eye color, the largest of its kind to date, which involved the analysis of 195,000 individuals across Europe and Asia. The analysis uncovered 61 discrete genomic regions, with 50 of them being newly identified regions, associated with eye color variation.

Genetics 59

Genetics Gene Genome Genomics 59

XTalks

MARCH 7, 2024

Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity This on-demand webinar introduces a cutting-edge single-cell multiomics method designed for garnering detailed genetic insights into breast cancer. The test accurately identified a range of genetic abnormalities, including trisomies and microdeletions.

Genetics 115

Genetics Hormones Genome Genomics 115

XTalks

DECEMBER 14, 2022

It’s a new genetic way of potentially targeting these really hard to treat diseases,” said Abudayyeh, a McGovern Fellow at MIT’s McGovern Institute for Brain Research, in MIT’s press release. Integrases are used by viruses called bacteriophages to insert their genetic material into bacteria.

Gene Editing 98

Gene Editing DNA Gene Gene Sequencing 98

pharmaphorum

AUGUST 11, 2022

There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. The participants undergo monitoring for genetic variations that could potentially negatively impact their reaction to therapies. About the Author.

Genome 98

Genome Genomics Drugs Genetics 98

XTalks

AUGUST 29, 2022

CRISPR is notable for engineering living cells, allowing scientists to edit, turn off, delete, or replace genes in a cell’s genome. It is difficult to control where the viral vectors insert genes in the genome, and it is difficult to manufacture large quantities of clinical-grade viral vectors. From the Bench to Patient Therapeutics.

Gene Editing 98

Gene Editing DNA Gene Genome 98

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Genuity Science focuses on population genomics as a tool to derive novel biological insights through partnerships with industry-leading pharmaceutical and biotech companies.

Research 98

Research Biobanking Drugs Genome 98

The Pharma Data

SEPTEMBER 28, 2020

Accenture Applied Intelligence announced a new data and analytics approach to manage and derive insights from paediatric acute myeloid leukaemia (AML) genomic data, with the potential to improve precision medicine. Insights from project could potentially improve precision medicine use for paediatric AML.

Genome 52

Genome Genomics Clinical Trials Clinical Trials 52

XTalks

MAY 20, 2022

Depending on the type of field or company, you can pursue clinical scientist jobs with a major in biology, medicine, medical technology, chemistry, immunology and other related life science and pre-medical degrees. Clinical Pharmaceutical Science. Genetic Science. Computer Science and Modeling. Microbiology.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

XTalks

AUGUST 5, 2020

Rosha Poudyal, PhD, Science and Technology Advisor at 10x Genomics, discussed some of the innovative single cell technology tools that the company is developing and their application in various research areas including oncology, infectious disease and immunology. Feature barcoding using gel beads. Chromium Single Cell Solutions.

Gene Expression 112

Gene Expression Development RNA Drugs 112

XTalks

SEPTEMBER 6, 2024

As the co-founder of Blueprint Genetics, a proud member of the Quest Diagnostics family, I’ve witnessed firsthand the complexities and nuances involved in rare disease diagnostics and the development of orphan drugs. At Blueprint Genetics, we are committed to making sense of this complexity.

Genetics 52

Genetics Drugs Development FDA Approval 52

The Pharma Data

DECEMBER 22, 2020

This assay enables clinical geneticists to detect genetic aberrations associated with developmental delay, intellectual disabilities, congenital anomalies, and unexplained dysmorphic features. “We are truly excited and humbled to bring the power of diagnostic microarray testing to the Japanese market. About Agilent Technologies.

Genome 40

Genome Genomics Genetics In-Vitro 40

pharmaphorum

OCTOBER 6, 2022

By reducing the disease to its key components, a computer-readable network of disease markers was characterised using genetic, biomarker, and clinical data; the model was also populated with ‘disease vs control’ data. Chris Cheadle is the Director of Research for Biology Products, Elsevier Life Sciences.

In-Vivo 98

In-Vivo Research Genetics Drugs 98

XTalks

JULY 14, 2022

On July 11 th , 2022, researchers at the Gladstone Institutes, UC San Francisco and Stanford School of Medicine published a study in Nature Genetics about using CRISPR technology to study the networks between thousands of genes simultaneously, as announced in a press release.

Gene 98

Gene Regulation Protein Gene Editing 98

XTalks

JULY 24, 2024

XTALKS WEBINAR: Digital Health Tools That Will Transform Cancer Treatment Live and On-Demand: Thursday, August 22, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn how pharmaceutical and life science technology companies are collaborating to harness digital health tools in oncology care delivery.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

XTalks

APRIL 5, 2021

Bioinformatics jobs are commonly found in the fields of computer information science, pharmaceuticals, biotechnology, medical technology, computational biology, proteomics and medical informatics. The Human Genome Project could not have succeeded without the use of bioinformatics. How to Become a Bioinformatics Analyst.

Bioinformatics 59

Bioinformatics Engineer Scientist Genome 59

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — Caris Life Sciences® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Winship Cancer Institute of Emory University (Winship) has joined Caris’ Precision Oncology Alliance (The Alliance/POA). .”

Life Science 52

Life Science Clinical Trials Clinical Trials RNA 52

XTalks

JANUARY 2, 2024

a biotech company specializing in the development and commercialization of genetic medicines for rare diseases, announced FDA approval for Vyjuvek for the treatment of DEB. Upon Vyjuvek’s entry into cells, the vector genome is integrated into the nucleus, initiating the transcription of the encoded human COL7A1.

FDA Approval 111

FDA Approval Gene Therapy Gene Trials 111

pharmaphorum

MARCH 19, 2021

Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves 1. As rare diseases are often genetic, triggers can include the diagnosis of a family member, a family member’s suggestion, or even the patient’s self-referral.

Branding 52

Branding Genome Genomics Genetics 52

Pharmaceutical Technology

JUNE 21, 2023

Life sciences venture capital firm Flagship Pioneering has unveiled Empress Therapeutics, a small molecule drug development startup. Empress benefits from a wealth of clinical data, and recent advances in genomics, artificial intelligence (AI) and synthetic biology.

Development 130

Development Drugs Protein Life Science 130

XTalks

DECEMBER 1, 2020

Fortunately, technological advances — such as those pioneered by Menarini Silicon Biosystems — have allowed researchers and healthcare practitioners to decipher these issues, drilling down to single-cell genomic levels to uncover variations that may account for reduced drug efficacy or biochemical resistance.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

XTalks

OCTOBER 20, 2023

Clinical-stage genome editing company Intellia Therapeutics has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to start a pivotal phase III trial of NTLA-2001 for the treatment of transthyretin (ATTR) amyloidosis with cardiomyopathy.

In-Vivo 52

In-Vivo Gene Editing Trials Gene 52

pharmaphorum

MARCH 28, 2022

But it always starts with the biology or the genetic pool that makes the natural antibodies. With over 20 years of experience in the Israeli biotech industry, Noga has previously held leadership roles at Zetiq, Rosetta Genomics, miCure and FutuRx. From there, they evaluate what kind of antibodies are produced. About the author .

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

XTalks

AUGUST 20, 2020

The COVID-19 wearables study was launched by the Stanford Healthcare Innovation lab, led by Michael Snyder, PhD, chair of the Department of Genetics and director of the Center for Genomics and Personalized Medicine at the Stanford University School of Medicine.

Research 98

Research Medicine Development Genome 98

Delveinsight

JANUARY 14, 2021

Technologists are getting better at coding biology, and venture firms are flooding a new generation of startups with cash to commercialize their technology bringing in the next wave of genetic innovation. Verve Therapeutics unveils its lead program for treating genetically high cholesterol.

Gene Editing 40

Gene Editing Gene Genetics DNA 40

XTalks

OCTOBER 4, 2024

Whole-Genome Sequencing Reveals Genetic Causes of Cerebral Palsy Canadian researchers have unveiled significant genetic factors that may contribute to the development of cerebral palsy. Additionally, 17.7

Genetics 52

Genetics Botox Research Development 52

XTalks

NOVEMBER 3, 2023

CRISPR works as genetic scissors to edit parts of the genome. The companies used data from the 1,000 Genomes Project but from that, only 61 datasets made the cut to encompass the ideal patient population. “I The CRISPR-Cas9 gene editing system was first discovered to be endogenous in bacteria.

Gene Therapy 59

Gene Therapy Gene Gene Editing In-Vivo 59

Pharmaceutical Technology

FEBRUARY 3, 2023

The field of genomic medicine has reached a true turning point. With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more.

Genome 244

Genome Genomics Medicine Gene Therapy 244